www.seqwright.com

Founded in 1994 by John W. Belmont, M.D., Ph.D. and Richard Gibbs, Ph.D., Director of the Human Genome Sequencing Center, SeqWright Inc. is a Contract Research Organization (CRO) specializing in Genomic Services. From its inception, Fei Lu, M.D. has run the Houston-based company, fostering its growth from a small start-up, focused primarily on sequencing, to a powerful full-service Nucleic Acid Technology CRO with services ranging from Molecular Biology, to Microarray, to Next Generation Sequencing.

SeqWright is CLIA certified and GLP compliant, thereby enabling it to offer FDA and GLP-level services; a strength the company has leveraged to offer Clinical Trial support services to the Pharmaceutical Industry and Genomics Services to the USDA. With over 13 years of Genomics experience, SeqWright has earned a reputation for quality service, technical expertise, and a willingness to customize services to meet client’s individual needs. The company’s reputation has facilitated the procurement of Preferred and Sole-Supplier status with Industry leaders from both the Pharmaceutical and Biotechnology Industries.

SeqWright continually seeks out synergistic partnerships and technologies to compliment its current offerings and to offer its clients the most complete and competitive line of Nucleic Acid-based services possible. As the company continues to expand into new markets, SeqWright’s core mission, to facilitate and accelerate the research of its clients and help drive innovation within the industry, will always endure.

Capabilities - SeqWright is a world-class genomics services company with over 13 years of experience and an established reputation for excellence within the field. Our facility houses an impressive array of advanced liquid-handling robotics and state-of-the-art genetic analysis equipment. Many of our customers are well-known leaders in their respective industries. SeqWright’s service catalog includes DNA sequencing, Microarray analysis, QPCR, Next Generation Sequencing, SNP detection, Genotyping, Microbial id, custom subcloning and mutagenesis, comprehensive bioinformatics and more.

Commitment to Quality (Certifications) – SeqWright’s secure facility is GLP compliant (21 CFR 58) and CLIA certified and it has implemented all applicable portions of cGMP guidelines. SeqWright is therefore capable of handling patient samples and producing reports for FDA submission. Additionally, SeqWright employs a state of the art workflow design, along with cutting-edge features which drastically reduce the potential for contamination. Data Security and Integrity is critically important to any Clinical Trial and therefore, SeqWright utilizes a LIMs tracking system which establishes a chain of custody to ensure client samples are always accounted for. Furthermore, SeqWright goes to great lengths to maintain and protect the integrity of client data through strong encryption, redundant fire walls, on and off-site secure storage, encrypted channel solutions for data transmission, and emergency power.

Competitive Pricing – SeqWright is committed to offering competitive pricing and value-enhanced services. We continually review our protocols and procedures in order to provide our clients with the most competitive pricing possible without compromising service quality.

Client Confidentiality – SeqWright understands that anonymity, confidentiality, and privacy are of paramount importance to all its customers. Therefore, all data and materials provided to SeqWright, as well as all contractual data produced by SeqWright, will remain strictly confidential and the sole property of the client. Furthermore, SeqWright is not focused on the research and development of intellectual property and therefore, there is no potential conflict of interest between SeqWright and its clients from the development of any new technologies or discoveries.

Phone: 713-528-4363
Fax: 713-528-6232
Email: sales@seqwright.com
Web: www.seqwright.com

SeqWright Inc.
2575 W. Bellfort Street, Suite 2001
Houston, TX 77054